The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors

Kim, H; Ahn, S; Kim, H; Hong, JY; Lee, J; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, KM; Kim, ST

Kim, ST (通讯作者),Sungkyunkwan Univ, Sch Med, Div Hematol Oncol, Dept Med,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022; 148 (9): 2427

Abstract

Purpose Homologous recombination deficiency (HRD) is related to tumorigenesis. Currently, the possibility of HRD as a prognostic biomarker to immune c......

Full Text Link